Aclaris Therapeutics Inc (ACRS) Stock Dips Amid Market Moves

Aclaris Therapeutics Inc (NASDAQ: ACRS) experienced a decline of -4.24%, closing at $2.36 on Wednesday after opening at $2.26. Over the long term, the stock has traded within a 52-week range of $1.05–$5.17.

The healthcare company has demonstrated 15.24% annual sales growth over the past five years, with a matching annual earnings per share (EPS) during the same period. For the current year, ACRS has posted a remarkable EPS growth of 68.91%. The company has 108.33 million shares outstanding and a float of 92.30 million, resulting in a market capitalization of $244.83 million. At present, the stock’s 50-day moving average is $2.03, while its 200-day moving average is $1.74.

ACRS Ownership Facts and Figures

Investor sentiment toward Aclaris shows 14.80% insider ownership and 73.50% institutional ownership. Notably, on Nov 19, 2024, a company director purchased 666,666 shares at $2.25, valuing the transaction at $1,499,998 and impacting insider ownership by 710,030 shares.

Aclaris Therapeutics Earnings and Revenue

Wall Street analysts anticipate a -0.15 EPS for the current fiscal year, with the stock’s EPS growth for the past 12 months at 68.91%. Analysts project EPS to reach -0.59 in the coming year. Looking further ahead, ACRS is expected to achieve 27.78% EPS growth over the next five years, surpassing its 15.24% growth over the past five years.

Aclaris Therapeutics Inc (ACRS) Trading Performance

Current performance indicators for ACRS include a quick ratio of 3.88 and a price-to-sales ratio of 14.58 over the trailing twelve months. The stock’s diluted EPS is -1.37, expected to reach -0.14 next quarter and -0.59 in one year.

Technical Analysis of ACRS

Over the past five days, ACRS trading volume exceeded 1.02 million, compared to the year-ago period. Its Stochastic %D over nine days is 49.31%, while the average true range (ATR) is 49.74. The 100-day stochastic average is 67.65%, up from 46.34% in the last two weeks, signaling a notable increase in momentum. Historical volatility over 14 days is 0.23, higher than 0.12 over 100 days, indicating growing price fluctuations.